» Articles » PMID: 33742045

Short and Long-read Genome Sequencing Methodologies for Somatic Variant Detection; Genomic Analysis of a Patient with Diffuse Large B-cell Lymphoma

Overview
Journal Sci Rep
Specialty Science
Date 2021 Mar 20
PMID 33742045
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Recent advances in throughput and accuracy mean that the Oxford Nanopore Technologies PromethION platform is a now a viable solution for genome sequencing. Much of the validation of bioinformatic tools for this long-read data has focussed on calling germline variants (including structural variants). Somatic variants are outnumbered many-fold by germline variants and their detection is further complicated by the effects of tumour purity/subclonality. Here, we evaluate the extent to which Nanopore sequencing enables detection and analysis of somatic variation. We do this through sequencing tumour and germline genomes for a patient with diffuse B-cell lymphoma and comparing results with 150 bp short-read sequencing of the same samples. Calling germline single nucleotide variants (SNVs) from specific chromosomes of the long-read data achieved good specificity and sensitivity. However, results of somatic SNV calling highlight the need for the development of specialised joint calling algorithms. We find the comparative genome-wide performance of different tools varies significantly between structural variant types, and suggest long reads are especially advantageous for calling large somatic deletions and duplications. Finally, we highlight the utility of long reads for phasing clinically relevant variants, confirming that a somatic 1.6 Mb deletion and a p.(Arg249Met) mutation involving TP53 are oriented in trans.

Citing Articles

The promising role of nanopore sequencing in cancer diagnostics and treatment.

Su X, Lin Q, Liu B, Zhou C, Lu L, Lin Z Cell Insight. 2025; 4(2):100229.

PMID: 39995512 PMC: 11849079. DOI: 10.1016/j.cellin.2025.100229.


Familial severe skeletal Class II malocclusion with gingival hyperplasia caused by a complex structural rearrangement at the KCNJ2-KCNJ16 locus.

Maroofian R, Pagnamenta A, Navabazam A, Schwessinger R, Roberts H, Lopopolo M HGG Adv. 2024; 5(4):100352.

PMID: 39257002 PMC: 11465088. DOI: 10.1016/j.xhgg.2024.100352.


A multiomic characterization of the leukemia cell line REH using short- and long-read sequencing.

Lysenkova Wiklander M, Arvidsson G, Bunikis I, Lundmark A, Raine A, Marincevic-Zuniga Y Life Sci Alliance. 2024; 7(8).

PMID: 38777370 PMC: 11111970. DOI: 10.26508/lsa.202302481.


Structural and non-coding variants increase the diagnostic yield of clinical whole genome sequencing for rare diseases.

Pagnamenta A, Camps C, Giacopuzzi E, Taylor J, Hashim M, Calpena E Genome Med. 2023; 15(1):94.

PMID: 37946251 PMC: 10636885. DOI: 10.1186/s13073-023-01240-0.


ImmunoTyper-SR: A computational approach for genotyping immunoglobulin heavy chain variable genes using short-read data.

Ford M, Hari A, Rodriguez O, Xu J, Lack J, Oguz C Cell Syst. 2022; 13(10):808-816.e5.

PMID: 36265467 PMC: 10084889. DOI: 10.1016/j.cels.2022.08.008.


References
1.
Horak P, Frohling S, Glimm H . Integrating next-generation sequencing into clinical oncology: strategies, promises and pitfalls. ESMO Open. 2016; 1(5):e000094. PMC: 5133384. DOI: 10.1136/esmoopen-2016-000094. View

2.
Burns A, Alsolami R, Becq J, Stamatopoulos B, Timbs A, Bruce D . Whole-genome sequencing of chronic lymphocytic leukaemia reveals distinct differences in the mutational landscape between IgHV and IgHV subgroups. Leukemia. 2017; 32(2):332-342. PMC: 5808074. DOI: 10.1038/leu.2017.177. View

3.
Robinson J, Thorvaldsdottir H, Winckler W, Guttman M, Lander E, Getz G . Integrative genomics viewer. Nat Biotechnol. 2011; 29(1):24-6. PMC: 3346182. DOI: 10.1038/nbt.1754. View

4.
Taylor J, Martin H, Lise S, Broxholme J, Cazier J, Rimmer A . Factors influencing success of clinical genome sequencing across a broad spectrum of disorders. Nat Genet. 2015; 47(7):717-726. PMC: 4601524. DOI: 10.1038/ng.3304. View

5.
Huang F, Hodis E, Xu M, Kryukov G, Chin L, Garraway L . Highly recurrent TERT promoter mutations in human melanoma. Science. 2013; 339(6122):957-9. PMC: 4423787. DOI: 10.1126/science.1229259. View